Quercetin for Anti-Inflammatory

Research suggests that quercetin, a flavonoid found naturally in foods such as onions, apples, berries, and broccoli, possesses broad anti-inflammatory properties supported by a substantial body of preclinical evidence, including numerous reviews of in vitro and animal studies showing that quercetin can inhibit key inflammatory pathways, suppress pro-inflammatory cytokines such as IL-1β, IL-6, and TNF-α, reduce histamine release, and modulate immune signaling cascades including NF-κB and the NLRP3 inflammasome. Studies indicate these effects may have relevance across a range of inflammation-related contexts, from allergic conditions like atopic dermatitis and asthma to neuroinflammation associated with neurodegenerative diseases, with some research also exploring topical applications for skin inflammation and metal-chelate formulations that may enhance anti-inflammatory potency. The available evidence is drawn predominantly from laboratory experiments and animal models, along with a number of narrative and scoping reviews, rather than large-scale human clinical trials, which means the translation of these findings to real-world therapeutic use in people remains an open question. A recurring theme across the literature is that quercetin's poor solubility and low bioavailability present practical challenges, and researchers are actively investigating delivery strategies such as nanoformulations and chemical derivatives to address these limitations before stronger conclusions about human efficacy can be drawn.